1. Home
  2. QVCGA vs SCYX Comparison

QVCGA vs SCYX Comparison

Compare QVCGA & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QVCGA
  • SCYX
  • Stock Information
  • Founded
  • QVCGA 1991
  • SCYX 1999
  • Country
  • QVCGA United States
  • SCYX United States
  • Employees
  • QVCGA N/A
  • SCYX N/A
  • Industry
  • QVCGA
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • QVCGA
  • SCYX Health Care
  • Exchange
  • QVCGA NYSE
  • SCYX Nasdaq
  • Market Cap
  • QVCGA 26.1M
  • SCYX 28.5M
  • IPO Year
  • QVCGA N/A
  • SCYX 2014
  • Fundamental
  • Price
  • QVCGA $2.64
  • SCYX $0.76
  • Analyst Decision
  • QVCGA
  • SCYX
  • Analyst Count
  • QVCGA 0
  • SCYX 0
  • Target Price
  • QVCGA N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • QVCGA 104.1K
  • SCYX 193.9K
  • Earning Date
  • QVCGA 08-07-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • QVCGA N/A
  • SCYX N/A
  • EPS Growth
  • QVCGA N/A
  • SCYX N/A
  • EPS
  • QVCGA N/A
  • SCYX N/A
  • Revenue
  • QVCGA $9,800,000,000.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • QVCGA $2.89
  • SCYX $410.22
  • Revenue Next Year
  • QVCGA $0.45
  • SCYX $248.83
  • P/E Ratio
  • QVCGA N/A
  • SCYX N/A
  • Revenue Growth
  • QVCGA N/A
  • SCYX N/A
  • 52 Week Low
  • QVCGA $2.27
  • SCYX $0.66
  • 52 Week High
  • QVCGA $39.74
  • SCYX $2.29
  • Technical
  • Relative Strength Index (RSI)
  • QVCGA N/A
  • SCYX 47.53
  • Support Level
  • QVCGA N/A
  • SCYX $0.67
  • Resistance Level
  • QVCGA N/A
  • SCYX $0.83
  • Average True Range (ATR)
  • QVCGA 0.00
  • SCYX 0.05
  • MACD
  • QVCGA 0.00
  • SCYX 0.01
  • Stochastic Oscillator
  • QVCGA 0.00
  • SCYX 49.12

About QVCGA QVC GROUP INC

QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: